News
The Exciting State of The Pharmaceutical Cold Chain Arena
In the past decade, there has been a rapid evolution in the industry practices related to delivering temperature-sensitive pharmaceuticals. During the 2000s, a pharmaceutical cold chain interest group emerged among industry experts with the aim to promote and come...
News
Fibre-Based Packaging: Way To A Sustainable Pharma Future?
It is impossible to ignore the worldwide push for sustainability. It indeed plays an increasingly significant role in shaping our daily lives, influencing everything from the vehicles we use to the food we consume. While prioritising the health of patients...
News
Husky Grabs The Innovation In Bioplastics Award For 2023
Husky Technologies has been announced as the recipient of PLASTICS' 2023 Innovation in Bioplastics Award by the Plastics Industry Association- PLASTICS. The announcement on October 4 was made during PLASTICS' 8th annual online event called #BioplasticsWeek, which strives to...
BioPharma
Cryoport, CGT Catapult Partner on Cell and Gene Therapies
Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, and the Cell and Gene Therapy Catapult,...
News
Cold Chain Technologies Acquires Exeltainer, Expanding its Presence in Europe and Latin America
Cold Chain Technologies, LLC, a leading provider of thermal packaging solutions for the transportation of temperature-sensitive products for the life sciences industry, announced it has acquired Exeltainer, a global provider of life sciences thermal packaging solutions with manufacturing hubs...
News
Drugmakers Enrol For First US Medicare Price Negotiations
All drug manufacturers responsible for manufacturing the 10 prescription medicines that will be subject to the inaugural price negotiations for the U.S. Medicare health programme, such as Amgen as well as Novartis, have confirmed their participation in the talks by the...
News
Europe Pharma Manufacturing Not In Best Shape With PFAS Cut
The European Federation of Pharmaceutical Industries and Associations (EFPIA) recently warned that more than 600 essential medicines could be at risk if suggested limitations on the use of fluorinated substances, especially per- and polyfluoroalkyl substances- PFAS, in pharmaceutical manufacturing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















